Search results

• Sulfamethoxazole
  ...is marketed as Biseptol. Its primary activity is against susceptible forms of ''[[Streptococcus]]'', ''[[Staphylococcus aureus]]'' (including [[Methicill == Mechanism of action ==
  7 KB (978 words) - 13:12, 20 September 2010
• Bromfenac
  ...drug was withdrawn from the US market and discontinued due to side effects of systemic, long-term administration. ==Chemistry==
  2 KB (227 words) - 13:12, 20 September 2010
• Arsanilic acid
  | ImageName = Chemical structure of arsanilic acid ...mageName1 = Ball-and-stick model of the solid-state zwitterionic structure of arsanilic acid
  5 KB (622 words) - 13:12, 20 September 2010
• 4-NEMD
  ...and William P. Ashman. 4-(1-(1-naphthalenyl)ethyl)- 1H- imidazole, method of making and use as an anesthetic agent. US patent 5151526.]</ref>
  3 KB (495 words) - 13:13, 20 September 2010
• (R)-3-Nitrobiphenyline
  ...icient and alpha2C-subtype selective agonist |journal=Journal of Medicinal Chemistry |volume=50 |issue=16 |pages=3964–8 |year=2007 |month=August |pmid=1763072
  2 KB (221 words) - 13:15, 20 September 2010
• Ergothioneine
  ...1.<ref name=Mann/> This amino acid has [[antioxidant]] properties, but its chemistry differs from conventional sulfur-containing antioxidants such as [[glutathi ...le DB, Otken CC, Kovalenko V |title=On the origin of animal ergothioneine |journal=J. Biol. Chem. |volume=216 |issue=1 |pages=325–31 |year=1955 |month=Septe
  12 KB (1,640 words) - 13:16, 20 September 2010
• COSHH
  Title=The Control of Substances Hazardous to Health Regulations 2002| ...implement several [[European Union directive]]s.<ref name="explan">Office of Public Sector Information (2002)</ref><ref name="brief">Health and Safety E
  21 KB (2,852 words) - 21:33, 20 September 2010
• Arsenic
  ...The occurrence of arsenic in drinking water is problematic in some parts of the world. ...per and lower layer. This relatively close packing leads to a high density of 5.73&nbsp;g/cm³.<ref name="Holl"/> It is a [[semiconductor]] an
  51 KB (7,314 words) - 21:34, 20 September 2010
• Partition coefficient
  ...cNaught, Alan D. | authorlink = | editor = | others = | title = Compendium of Chemical Terminology: IUPAC Recommendations | edition = | language = | publ ...ntially distributed to hydrophobic compartments such as [[lipid bilayers]] of cells while hydrophilic drugs (low partition coefficients) preferentially a
  27 KB (3,780 words) - 20:16, 21 September 2010
• Acid dissociation constant
  ...-3D-balls.png|thumb|305px|alt=Acetic acid, CH₃COOH, is composed of a methyl group, CH₃, bound chemically to a carboxylate group, CO ...reaction known as [[Dissociation (chemistry)|dissociation]] in the context of [[acid-base reactions]]. The equilibrium can be written symbolically as:
  76 KB (11,861 words) - 20:17, 21 September 2010
• Ligand
  {{about|ligands in inorganic chemistry|ligands in biochemistry|Ligand (biochemistry)|other uses|Ligand (disambigua ...mal donation of one or more of the ligand's [[electron]] pairs. The nature of metal-ligand bonding can range from [[covalent bond|covalent]] to ionic. Fu
  25 KB (3,607 words) - 20:18, 21 September 2010
• Cannabinoid
  ...tem: drug targets, lead compounds, and potential therapeutic applications |journal=J. Med. Chem. |volume=48 |issue=16 |pages=5059–87 |year=2005 |pmid=160788 ...Mo FM, Liu J, Kunos G | title = Evidence for novel cannabinoid receptors | journal = Pharmacol. Ther. | volume = 106 | issue = 2 | pages = 133–45 | year = 2
  49 KB (6,487 words) - 22:06, 21 September 2010
• Kratom
  '''Kratom''' (''Mitragyna speciosa'') is a medicinal leaf harvested from a large tree in the Rubiaceae family native to [[Southe ...agynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.) |journal=J Ethnopharmacol |volume= |issue= |pages= |year=2010 |month=April |pmid=203
  17 KB (2,570 words) - 22:07, 21 September 2010
• Gabapentin enacarbil
  ...n alternative treatment to dopaminergic agents for restless legs syndrome |journal=Expert Opinion on Pharmacotherapy |volume=11 |issue=11 |pages=1925–32 |ye ...treatment of restless legs syndrome was not seen to justify the same kind of risk.<ref>[http://www.tradingmarkets.com/news/stock-alert/gsk_glaxosmithkli
  5 KB (682 words) - 22:07, 21 September 2010
• Cannabinol
  ...nd antagonist activity of cannabidiol on rat brain cannabinoid receptors | journal = Life Sciences | volume = 63 | issue = 1 | pages = PL1–6 | year = 1998 |
  3 KB (352 words) - 22:07, 21 September 2010
• Cannabidiol
  ...is and Cannabis Extracts: Greater Than the Sum of Their Parts?]. ''Journal of Cannabis Therapeutics''. 1(3/4):103-132.</ref> ...lant, representing up to 40% in its extracts.<ref name="Grlie_1976">{{cite journal
  17 KB (2,198 words) - 22:07, 21 September 2010
• THC-O-phosphate
  ...the slow rate of hydrolysis of the ester link, resulting in delayed onset of action and lower potency than the parent drug. ...of a phosphate ester of delta8-tetrahydrocannabinol. Journal of Medicinal Chemistry. 1978 Oct;21(10):1079-81. </ref>
  2 KB (227 words) - 22:08, 21 September 2010
• JWH-015
  ...f cannabinoid receptor 2 (CB2) suppresses microglial activation. ''Journal of Neuroinflammation''. 2005 Dec 12;2:29. PMID 16343349</ref><ref>Romero-Sando ...;30(10):1077-86. PMID 12228183</ref> [[Benzo(a)pyrene#Toxicity|Epoxidation of polycyclic aromatic hydrocarbons]] can produce [[carcinogenic]] metabolites
  4 KB (576 words) - 22:08, 21 September 2010
• JWH-200
  ...mpounds structurally distinct from delta 9-tetrahydrocannabinol. ''Journal of Pharmacology and Experimental Therapeutics''. 263 (3): 1118–26. PMID 1335
  3 KB (336 words) - 22:08, 21 September 2010
• AM-411
  ...nalgesic]] drug which is a [[cannabinoid]] [[agonist]]. It is a derivative of Δ8[[THC]] substituted with an [[adamantane|adamantyl]] group at the 3-posi ...on KM, Thakur G, Swezey LA, Makriyannis A, Salamone JD. Behavioral effects of the novel cannabinoid full agonist AM 411. ''Pharmacology, Biochemistry and
  2 KB (287 words) - 22:08, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)